172 related articles for article (PubMed ID: 32141310)
1. Monocyte count and the risk for acute exacerbation of fibrosing interstitial lung disease: A retrospective cohort study.
Kawamura K; Ichikado K; Anan K; Yasuda Y; Sekido Y; Suga M; Ichiyasu H; Sakagami T
Chron Respir Dis; 2020; 17():1479973120909840. PubMed ID: 32141310
[TBL] [Abstract][Full Text] [Related]
2. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
[TBL] [Abstract][Full Text] [Related]
3. Acute exacerbations of fibrotic interstitial lung diseases.
Suzuki A; Kondoh Y; Brown KK; Johkoh T; Kataoka K; Fukuoka J; Kimura T; Matsuda T; Yokoyama T; Fukihara J; Ando M; Tanaka T; Hashimoto N; Sakamoto K; Hasegawa Y
Respirology; 2020 May; 25(5):525-534. PubMed ID: 31426125
[TBL] [Abstract][Full Text] [Related]
4. Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort study.
Scott MKD; Quinn K; Li Q; Carroll R; Warsinske H; Vallania F; Chen S; Carns MA; Aren K; Sun J; Koloms K; Lee J; Baral J; Kropski J; Zhao H; Herzog E; Martinez FJ; Moore BB; Hinchcliff M; Denny J; Kaminski N; Herazo-Maya JD; Shah NH; Khatri P
Lancet Respir Med; 2019 Jun; 7(6):497-508. PubMed ID: 30935881
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease.
Kono M; Miyashita K; Hirama R; Oshima Y; Takeda K; Mochizuka Y; Tsutsumi A; Miwa H; Miki Y; Hashimoto D; Suda T; Nakamura H
Respir Med; 2021 Sep; 186():106534. PubMed ID: 34260978
[TBL] [Abstract][Full Text] [Related]
6. Causes of acute respiratory hospitalizations predict survival in fibrosing interstitial lung diseases.
Salonen J; Vähänikkilä H; Purokivi M; Kaarteenaho R
PLoS One; 2020; 15(11):e0242860. PubMed ID: 33253258
[TBL] [Abstract][Full Text] [Related]
7. Acute exacerbation of chronic fibrosing interstitial pneumonia in patients receiving antifibrotic agents: incidence and risk factors from real-world experience.
Kawamura K; Ichikado K; Ichiyasu H; Anan K; Yasuda Y; Suga M; Sakagami T
BMC Pulm Med; 2019 Jun; 19(1):113. PubMed ID: 31238929
[TBL] [Abstract][Full Text] [Related]
8. Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases.
Salonen J; Purokivi M; Bloigu R; Kaarteenaho R
BMJ Open Respir Res; 2020 Apr; 7(1):. PubMed ID: 32265195
[TBL] [Abstract][Full Text] [Related]
9. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.
Miyashita K; Kono M; Saito G; Koyanagi Y; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Nakamura Y; Suda T; Nakamura H
Clin Respir J; 2021 Mar; 15(3):336-344. PubMed ID: 33197284
[TBL] [Abstract][Full Text] [Related]
10. The Burden of Progressive Fibrosing Interstitial Lung Disease: A DELPHI Approach.
Wuyts WA; Papiris S; Manali E; Kilpeläinen M; Davidsen JR; Miedema J; Robalo-Cordeiro C; Morais A; Artés M; Asijee G; Cendoya D; Soulard S
Adv Ther; 2020 Jul; 37(7):3246-3264. PubMed ID: 32445186
[TBL] [Abstract][Full Text] [Related]
11. Re-hospitalisation predicts poor prognosis after acute exacerbation of interstitial lung disease.
Salonen J; Jansa S; Vähänikkilä H; Kaarteenaho R
BMC Pulm Med; 2023 Jul; 23(1):236. PubMed ID: 37393286
[TBL] [Abstract][Full Text] [Related]
12. Clinical features and outcome of acute exacerbation in connective tissue disease-associated interstitial lung disease: A single-center study from India.
Singh P; Thakur B; Mohapatra AK; Padhan P
Int J Rheum Dis; 2019 Sep; 22(9):1741-1745. PubMed ID: 31328423
[TBL] [Abstract][Full Text] [Related]
13. The Interstitial Lung Disease-Gender-Age-Physiology Index Can Predict the Prognosis in Surgically Resected Patients with Interstitial Lung Disease and Concomitant Lung Cancer.
Ueno F; Kitaguchi Y; Shiina T; Asaka S; Yasuo M; Wada Y; Kinjo T; Yoshizawa A; Hanaoka M
Respiration; 2020; 99(1):9-18. PubMed ID: 31554007
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of serum oncomarkers for patients hospitalized with acute exacerbation of interstitial lung disease.
Ba C; Jiang C; Wang H; Shi X; Jin J; Fang Q
Ther Adv Respir Dis; 2024; 18():17534666241250332. PubMed ID: 38757948
[TBL] [Abstract][Full Text] [Related]
15. Claims-based Prevalence of Disease Progression among Patients with Fibrosing Interstitial Lung Disease Other than Idiopathic Pulmonary Fibrosis in the United States.
Singer D; Bengtson LGS; Conoscenti CS; Laouri M; Shetty SS; Anderson AJ; Brown KK
Ann Am Thorac Soc; 2022 Jul; 19(7):1112-1121. PubMed ID: 35015982
[No Abstract] [Full Text] [Related]
16. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
Hyldgaard C
Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum D-dimer level is associated with an increased risk of acute exacerbation in interstitial lung disease.
Ishikawa G; Acquah SO; Salvatore M; Padilla ML
Respir Med; 2017 Jul; 128():78-84. PubMed ID: 28610674
[TBL] [Abstract][Full Text] [Related]
18. Frequency, proportion of PF-ILD, and prognostic factors in patients with acute exacerbation of ILD related to systemic autoimmune diseases.
Enomoto N; Naoi H; Mochizuka Y; Isayama T; Tanaka Y; Fukada A; Aono Y; Katsumata M; Yasui H; Mori K; Karayama M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
BMC Pulm Med; 2022 Oct; 22(1):387. PubMed ID: 36289542
[TBL] [Abstract][Full Text] [Related]
19. Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA.
Olson AL; Maher TM; Acciai V; Mounir B; Quaresma M; Zouad-Lejour L; Wells CD; De Loureiro L
Adv Ther; 2020 Jul; 37(7):3292-3298. PubMed ID: 32451950
[TBL] [Abstract][Full Text] [Related]
20. Patients With Fibrotic Interstitial Lung Disease Hospitalized for Acute Respiratory Worsening: A Large Cohort Analysis.
Moua T; Westerly BD; Dulohery MM; Daniels CE; Ryu JH; Lim KG
Chest; 2016 May; 149(5):1205-14. PubMed ID: 26836940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
